Company Number: 15142992

Analysis Date: 2025-07-20 18:44 UTC

Financial Health Assessment for DATAH2O LTD

---

1. Financial Health Score: Grade F

Explanation:
DATAH2O LTD exhibits significant financial distress reflected by negative net current assets and net assets of -£33,524. This suggests the company’s current liabilities exceed its current assets by a large margin, indicating an inability to cover short-term debts from available liquid resources. Such a position signals severe liquidity and solvency issues at this early stage of operation.

---

2. Key Vital Signs

Metric	Value	Interpretation
Current Assets	£3,747	Cash and receivables are minimal, indicating limited liquid resources.
Current Liabilities	£37,271	High level of short-term debts due within a year compared to current assets.
Net Current Assets (Working Capital)	-£33,524	Negative working capital—a critical symptom of financial distress; company cannot meet short-term obligations with current assets.
Net Assets (Shareholders Funds)	-£33,524	Negative equity suggests accumulated losses or funding deficits, indicating insolvency risk.
Employees	0	No staff employed, suggesting minimal operational activity or very early business stage.
Going Concern Statement	Supported by director’s commitment	The company depends entirely on the director’s financial support to continue; external financing or operational cash flow is absent.

---

3. Diagnosis

DATAH2O LTD is in a precarious financial condition, showing classic symptoms of distress such as negative working capital and equity. Despite being a very new micro-entity (incorporated less than 1 year), the company’s liabilities substantially outweigh its assets. This imbalance indicates either initial borrowing to fund startup costs or outstanding payables without sufficient liquid assets to cover them. The director’s statement about ongoing support is a critical factor keeping the company afloat—without this “lifeline,” the company’s viability would be in serious doubt.

The lack of employees and minimal current assets imply the company is either pre-revenue or in a development phase, typical for early-stage tech or consulting businesses, but the negative net assets highlight urgent financial challenges. The company’s classification under engineering consulting and software development suggests high upfront costs but so far no operational scale or revenue generation to offset liabilities.

---

4. Recommendations

• Urgent Cash Flow Management:
  The company must secure immediate additional funding (equity injection or short-term loan) to cover current liabilities and restore positive working capital. Without healthy cash flow, the risk of insolvency is high.

• Cost Control and Operational Planning:
  Review all liabilities to identify non-essential creditors or overdue payables that can be renegotiated or deferred. Implement strict expense controls to avoid further depletion of resources.

• Revenue Generation Strategy:
  Accelerate client acquisition or project delivery to generate income promptly. Develop clear milestones and financial forecasts to monitor progress.

• Director Support and External Funding:
  While director support is sustaining the company, reliance solely on this is risky. Explore external investors, grants, or business loans to diversify funding sources.

• Financial Reporting and Monitoring:
  Improve financial record-keeping and monthly cash flow forecasting to detect financial distress symptoms early and respond proactively.

• Consider Professional Advice:
  Engage a financial advisor or insolvency practitioner for early-stage restructuring advice to prevent escalation to formal insolvency processes.

---

Medical Analogy Summary

DATAH2O LTD currently shows critical symptoms of financial distress akin to a patient with dangerously low blood pressure and insufficient oxygen supply—here, the “oxygen” is cash and liquid assets, which are insufficient to meet immediate “metabolic” needs (liabilities). The director’s financial support acts like emergency life support, but for long-term survival, the company needs a treatment plan involving infusion of new capital, stabilization of expenses, and restoration of healthy cash flow.

---